When they were administered to breast cancer-bearing models, the BRD4 degradation and photodynamic therapy (PDT) cooperatively boosted the apoptosis of cancer cells, thereby achieving efficient tumor regression. The gene discussed is BRD4; the disease is breast carcinoma.